Controversy is a curious thing, especially when you throw today’s communication technology into the mix. Everybody has an opinion about everything, and
takes to a keyboard to share it with the world.
Roche and reMYND, developer of treatments against protein
misfolding disorders, jointly pursue disease-modifying programs for Parkinson’s and Alzheimer’s diseases